Dietary dilemmas in the management of glycogen storage disease type I
- PMID: 21491105
- DOI: 10.1007/s10545-011-9322-8
Dietary dilemmas in the management of glycogen storage disease type I
Abstract
Over the last 50 years, understanding the biochemical bases of glycogen storage disease type I has led to vastly improved survival and health outcomes but the management still centres around an extremely intensive dietary regimen. Patients' metabolic profiles are really determined by the whole of the diet and it can be very difficult to adjust therapy accordingly. In an iso-energetic diet with reference total energy intake, high carbohydrate intake could compromise other macro- and micro-nutrients; if carbohydrates are not restricted then total energy intake is excessive. The quality of the macronutrient such as the glycemic index of carbohydrate, the type of sugar and the proportion of medium-chain triglyceride and essential fatty acids also has a bearing on an individual's long-term metabolic control with potential clinical correlates. These factors as well as the different requirements between individuals and within individuals as they get older mean that the management of glycogen storage disease type I is particularly fraught. Regular clinical and dietary review is imperative as patients grow, ensuring adequate but not excessive low glycaemic index carbohydrate intake, appropriate dynamic biochemical profiles and suitable age appropriate eating patterns. Without diligent management, and education that empowers the patient, these individuals can struggle in adult life.
Similar articles
-
Diet and growth of children with glycogen storage disease Types I and III.J Am Diet Assoc. 1983 Aug;83(2):135-41. J Am Diet Assoc. 1983. PMID: 6409953
-
Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth.Ann Nutr Metab. 2010;56(3):225-32. doi: 10.1159/000283242. Epub 2010 Mar 30. Ann Nutr Metab. 2010. PMID: 20357432
-
Hepatic glycogen storage disorders: what have we learned in recent years?Curr Opin Clin Nutr Metab Care. 2015 Jul;18(4):415-21. doi: 10.1097/MCO.0000000000000181. Curr Opin Clin Nutr Metab Care. 2015. PMID: 26001652 Review.
-
Association between Macronutrient Intake and Excessive Daytime Sleepiness: An Iso-Caloric Substitution Analysis from the North West Adelaide Health Study.Nutrients. 2019 Oct 5;11(10):2374. doi: 10.3390/nu11102374. Nutrients. 2019. PMID: 31590356 Free PMC article.
-
Physical exercise as a modulator of adaptation to low and high carbohydrate and low and high fat intakes.Eur J Clin Nutr. 1999 Apr;53 Suppl 1:S112-9. doi: 10.1038/sj.ejcn.1600751. Eur J Clin Nutr. 1999. PMID: 10365988 Review.
Cited by
-
ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I.Rev Paul Pediatr. 2021 Feb 5;39:e2020046. doi: 10.1590/1984-0462/2021/39/2020046. eCollection 2021. Rev Paul Pediatr. 2021. PMID: 33566881 Free PMC article.
-
Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.J Inherit Metab Dis. 2021 Jul;44(4):879-892. doi: 10.1002/jimd.12380. Epub 2021 Apr 7. J Inherit Metab Dis. 2021. PMID: 33739445 Free PMC article.
-
Investigation and management of the hepatic glycogen storage diseases.Transl Pediatr. 2015 Jul;4(3):240-8. doi: 10.3978/j.issn.2224-4336.2015.04.07. Transl Pediatr. 2015. PMID: 26835382 Free PMC article. Review.
-
Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.J Inherit Metab Dis. 2015 Nov;38(6):1093-8. doi: 10.1007/s10545-015-9864-2. Epub 2015 Jun 25. J Inherit Metab Dis. 2015. PMID: 26109257 Clinical Trial.
-
Glycogen Storage Disease type 1a - a secondary cause for hyperlipidemia: report of five cases.J Diabetes Metab Disord. 2013 Jun 6;12(1):25. doi: 10.1186/2251-6581-12-25. J Diabetes Metab Disord. 2013. PMID: 23738826 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources